Collegium Pharmaceutical, Inc. COLL
22.53
(0.11)
(0.49%)
as of 25 Sep
- Market cap
- $737.1M
- P/E
- 14.7×
Follow COLL
Growth Flags
show if company had growth for consecutive years
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 26.01 | 9.29 | 0.00 | 21.24 | 13.39 | 23.15 |
P/S ratio |
0.00 | 19.87 | 2.02 | 2.32 | 2.22 | 2.36 | 1.72 | 1.86 | 1.46 | 1.88 |
P/FCF ratio |
0.00 | 0.00 | 3.97 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(16.34) | (42.57) | 13.38 | 43.98 | 30.53 | 18.03 | 12.03 | 14.37 | 10.92 | 11.93 |
P/B ratio |
2.82 | 5.44 | 6.18 | 7.87 | 3.70 | 3.22 | 4.09 | 5.39 | 4.04 | 4.87 |
Price to Tangible BV |
2.86 | 5.54 | 11.95 | 11.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 15.77 | 1.54 | 1.79 | 2.49 | 2.59 | 2.86 | 2.49 | 2.52 | 2.40 |
EV/EBITDA |
0.00 | 0.00 | 4.77 | 0.00 | 6.56 | 8.28 | 7.69 | 4.48 | 4.72 | 4.62 |
EV/Operating CF |
(3.08) | (6.70) | 2.54 | 19.08 | 8.22 | 6.92 | 10.67 | 5.13 | 7.75 | 5.68 |
EV/FCF |
(3.06) | (6.60) | 3.02 | (16,561.38) | (2.76) | (2.69) | (5.39) | (15.01) | (9.64) | (46.03) |
Quick Ratio |
6.07 | 4.09 | 1.19 | 1.20 | 1.08 | 1.05 | 0.82 | 1.07 | 0.82 | 1.40 |
Current Ratio |
6.20 | 4.24 | 1.26 | 1.27 | 1.16 | 1.13 | 0.97 | 1.17 | 0.95 | 1.57 |
Net Debt/EBITDA |
1.60 | 1.57 | (1.50) | 19.18 | 0.70 | 0.73 | 3.06 | 1.13 | 1.97 | 1.00 |
Debt/Assets |
2.56% | 1.09% | 3.95% | 3.75% | 39.93% | 36.12% | 59.70% | 58.35% | 51.24% | 48.85% |
Debt/Equity |
0.03 | 0.01 | 0.13 | 0.13 | 1.38 | 1.23 | 3.60 | 3.41 | 3.73 | 2.68 |
Asset Turnover |
0.01 | 0.19 | 1.31 | 0.99 | 0.65 | 0.41 | 0.50 | 0.49 | 0.45 | 0.47 |
Operating CF/Net income |
0.80 | 0.90 | (4.33) | (1.22) | 3.51 | 1.45 | (4.97) | 5.71 | 2.96 | 5.24 |
Capex/Depreciation |
(0.73) | (1.67) | (0.22) | (0.42) | (6.07) | (0.03) | (0.01) | 0.00 | (0.01) | (0.01) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (85.62%) | (62.65%) | (39.99%) | (25.39%) | 19.57% | 36.77% | (12.57%) | 24.68% | 32.62% | 23.70% | |
| (72.52%) | (50.32%) | (18.33%) | (7.61%) | 5.63% | 10.71% | (2.68%) | 4.16% | 4.93% | 3.79% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 13.06% | 4.13% | 2.88% | 18.90% | 11.88% | 15.94% |
Return on Tangible Assets |
(70.27%) | (72.11%) | (67.86%) | (34.53%) | 46.59% | 128.93% | (432.26%) | 50.34% | (535.36%) | 23.87% |
Average Days of Receivables |
454.17 | 127.78 | 101.46 | 89.75 | 98.10 | 139.54 | 144.07 | 115.61 | 132.10 | 98.82 |
Research and Development Expense of Revenue |
873.64% | 30.10% | 3.09% | 3.48% | 3.15% | 3.41% | 0.86% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
4,712.57% | 325.73% | 45.20% | 39.25% | 36.72% | 42.97% | 37.11% | 28.09% | 33.31% | 36.49% |
Intangible Assets out of Total Assets |
0.01 | 0.00 | 0.15 | 0.10 | 0.52 | 0.39 | 0.60 | 0.49 | 0.63 | 0.49 |
Share Based Compensation of Revenue |
338.22% | 27.90% | 4.91% | 5.57% | 7.07% | 8.76% | 4.93% | 4.79% | 5.13% | 5.37% |
Graham Net Nets |
0.35 | 0.18 | 0.07 | 0.05 | (0.26) | (0.27) | (0.70) | (0.39) | (1.03) | (0.45) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 9.68 | 16.21 | 0.00 | 13.84 | 18.48 | 20.69 |
Earnings Yield |
(24.74%) | (13.37%) | (6.99%) | (3.30%) | 3.84% | 10.76% | (3.12%) | 4.71% | 7.47% | 4.32% |
Free Cash Flow Yield |
(19.90%) | (12.02%) | 25.19% | 0.00% | (40.60%) | (40.85%) | (30.79%) | (8.91%) | (17.83%) | (2.77%) |
Revenue per Share |
0.07 | 0.94 | 8.51 | 8.87 | 9.01 | 7.92 | 13.71 | 16.80 | 19.57 | 24.62 |
Operating CF per Share |
(3.09) | (2.21) | 5.14 | 0.83 | 2.73 | 2.96 | 3.67 | 8.14 | 6.35 | 10.39 |
Capex per Share |
(0.02) | (0.03) | (0.74) | (0.19) | (10.86) | (0.06) | (0.05) | (0.01) | (0.05) | (0.05) |
Free Cash Flow per Share |
(3.11) | (2.25) | 4.40 | 0.64 | (8.13) | 2.91 | 3.62 | 8.13 | 6.30 | 10.33 |
Cash per Share |
6.32 | 3.92 | 4.45 | 5.08 | 5.06 | 5.34 | 5.13 | 9.20 | 5.82 | 12.82 |
Shareholders Equity per Share |
5.56 | 3.44 | 2.78 | 2.61 | 5.41 | 5.81 | 5.76 | 5.79 | 7.09 | 9.51 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
5.56 | 3.44 | 2.78 | 2.61 | 5.41 | 5.81 | 5.76 | 5.79 | 7.09 | 9.51 |
Free Cash Flow |
(75.53) | (68.01) | 145.04 | 21.35 | (279.83) | 101.61 | 122.61 | 274.29 | 203.33 | 327.58 |
Working Capital |
132.98 | 102.00 | 48.39 | 53.96 | 38.44 | 35.98 | (13.74) | 79.69 | (27.25) | 251.38 |
Capital Expenditures |
(0.48) | (0.99) | (24.35) | (6.44) | (373.77) | (1.94) | (1.62) | (0.46) | (1.65) | (1.74) |
Net Current Asset Value |
131.47 | 102.00 | 37.85 | 36.85 | (179.92) | (173.61) | (559.30) | (410.28) | (952.49) | (663.75) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 13.73 | 40.63 | 39.77 | 8.45 | 9.36 | 10.41 |
Capex to Sales |
0.28 | 0.03 | 0.09 | 0.02 | 1.21 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
(5,504.15%) | (262.91%) | (13.95%) | (7.66%) | 8.63% | 25.83% | (5.39%) | 8.50% | 10.96% | 8.05% |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 12.26 | 37.02 | 23.94 | 6.31 | 5.44 | 8.17 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.63 | 0.33 | 11.96 | 1.31 | 3.24 | 3.54 | 7.12 | 9.26 | 11.66 | 18.73 |
Cash ROIC |
(26.03%) | (30.70%) | 64.12% | 5.92% | 12.14% | 13.15% | 9.79% | 22.06% | 15.02% | 20.91% |
Accounts Receivable Turnover |
0.28 | 4.71 | 6.38 | 3.93 | 3.97 | 2.93 | 3.21 | 3.13 | 3.09 | 3.55 |
Accounts Payable Turnover |
0.03 | 0.35 | 18.58 | 21.05 | 16.01 | 17.78 | 66.24 | 39.49 | 40.25 | 43.49 |
Inventory Turnover |
0.14 | 1.66 | 34.41 | 22.18 | 10.31 | 7.65 | 7.96 | 6.10 | 7.49 | 8.30 |
Average Days of Payables |
15,604.18 | 799.48 | 26.77 | 11.77 | 28.08 | 12.11 | 5.01 | 13.19 | 5.65 | 12.26 |
Days of Inventory on Hand |
2,255.12 | 255.01 | 17.22 | 18.17 | 43.78 | 50.29 | 66.71 | 49.05 | 51.08 | 47.06 |
Average Receivables |
6.05 | 6.05 | 43.96 | 75.45 | 78.14 | 94.58 | 144.48 | 181.32 | 204.03 | 219.93 |
Average Payables |
6.32 | 7.40 | 8.92 | 9.20 | 8.13 | 7.10 | 3.84 | 6.09 | 6.31 | 7.30 |
Average Inventory |
1.56 | 1.56 | 4.82 | 8.73 | 12.63 | 16.50 | 31.95 | 39.42 | 33.95 | 38.24 |
Average Assets |
129.87 | 148.79 | 213.41 | 298.77 | 475.07 | 667.96 | 933.10 | 1,158.72 | 1,403.45 | 1,660.21 |
Average Common Equity |
109.99 | 119.49 | 97.83 | 89.51 | 136.73 | 194.48 | 198.89 | 195.14 | 212.14 | 265.26 |
Columns are period end dates